Trial Profile
Evaluation of perioperative changes of blood coagulation factors in patients with left ventricular assist device implantation and impact of XIII factors in postoperative hemostasis after LVAD implantation
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2020
Price :
$35
*
At a glance
- Drugs Factor XIII (Primary)
- Indications Blood coagulation disorders
- Focus Adverse reactions
- 17 Aug 2020 Status changed from active, no longer recruiting to discontinued.
- 07 May 2019 Status changed from recruiting to active, no longer recruiting.
- 01 Jul 2017 Status changed from not yet recruiting to recruiting.